1. Home
  2. TBRG vs MDWD Comparison

TBRG vs MDWD Comparison

Compare TBRG & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBRG
  • MDWD
  • Stock Information
  • Founded
  • TBRG 1979
  • MDWD 2000
  • Country
  • TBRG United States
  • MDWD Israel
  • Employees
  • TBRG N/A
  • MDWD N/A
  • Industry
  • TBRG
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • TBRG
  • MDWD Health Care
  • Exchange
  • TBRG NYSE
  • MDWD Nasdaq
  • Market Cap
  • TBRG 186.6M
  • MDWD 179.1M
  • IPO Year
  • TBRG N/A
  • MDWD 2014
  • Fundamental
  • Price
  • TBRG $12.35
  • MDWD $17.80
  • Analyst Decision
  • TBRG Buy
  • MDWD Strong Buy
  • Analyst Count
  • TBRG 2
  • MDWD 1
  • Target Price
  • TBRG $13.50
  • MDWD $28.00
  • AVG Volume (30 Days)
  • TBRG 57.4K
  • MDWD 60.7K
  • Earning Date
  • TBRG 11-06-2024
  • MDWD 08-14-2024
  • Dividend Yield
  • TBRG N/A
  • MDWD N/A
  • EPS Growth
  • TBRG N/A
  • MDWD N/A
  • EPS
  • TBRG N/A
  • MDWD N/A
  • Revenue
  • TBRG $336,557,000.00
  • MDWD $20,141,000.00
  • Revenue This Year
  • TBRG $0.94
  • MDWD $30.16
  • Revenue Next Year
  • TBRG $4.58
  • MDWD $18.44
  • P/E Ratio
  • TBRG N/A
  • MDWD N/A
  • Revenue Growth
  • TBRG N/A
  • MDWD N/A
  • 52 Week Low
  • TBRG $7.55
  • MDWD $7.45
  • 52 Week High
  • TBRG $17.28
  • MDWD $24.00
  • Technical
  • Relative Strength Index (RSI)
  • TBRG 48.70
  • MDWD 50.02
  • Support Level
  • TBRG $11.77
  • MDWD $16.25
  • Resistance Level
  • TBRG $12.84
  • MDWD $17.90
  • Average True Range (ATR)
  • TBRG 0.40
  • MDWD 0.97
  • MACD
  • TBRG -0.10
  • MDWD -0.05
  • Stochastic Oscillator
  • TBRG 20.54
  • MDWD 36.98

About TBRG TRUBRIDGE INC

TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The segments of the company are RCM, EHR, and Patient Engagement. The company derives maximum revenue from the RCM segment.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: